HMF - KEY TO GREEN CHEMISTRY - THE KEY TO GREEN CHEMISTRY Dr. Gilbert Anderer R&D H2020 Projects - DayOne
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
THE KEY TO GREEN CHEMISTRY
Dr. Gilbert Anderer
HMF – KEY TO GREEN CHEMISTRY
R&D H2020 Projects
Company at a glance
Ava AVA Biochem
Founded Biochem today
founded
2009 2011 2017
100% 14 20
privately owned related patents Experts
from 6 nations
2
Why HMF?
• Sugar over
production 5-HMF
• (Fructose)
Fructose 5-HMF: 5-Hydroxymethylfurfural
The Key To Green Chemistry 3
Replacement of fossil Formaldehyde Improve
based PET with bio- replacement in Health & Wellbeing
based PEF composite materials
Legislation
Improved barrier Health benefits
restrictions on
properties
formaldehyde
Recyclability Non-toxic New functionality
Strength Bio-based Bio-based
• Bottles • Fiber boards • Pharmaceuticals
• Fibers • Laminated wood • Dietetic Additives
• Films panels • Food and Beverage
• Tires • Tires Ingredient
4
EnzOx2: Enzymatic oxidation/oxyfunctionalization
The EnzOx2 Project is a Research & Innovation Action
funded by the Bio-based Industries Joint Undertaking,
a Public-Private Partnership between the EU (under
H2020 framework programme) and the Bio-based
Industries Consortium.
Detailed information: www.enzox2.eu
5
EnzOx2: Enzymatic oxidation/oxyfunctionalization
The overall aim of the EnzOx2 project is to
• develop new bio-chemical technologies
• based on the use of oxidative enzymes
• to provide innovative solutions for the production of substitutes to
products with petro-chemical origin.
Cordinator: CIB, CSIC Madrid
Duration: 01.11.16 – 31.10.16
Budget: 5 Mio € / Funding 4.7 Mio €
Participants: 3 SMEs, 2 Large Enterprises, 6 research institutes / Universities
AVA‘s funding: was sponsored by SBFI (Staatssekretariat für Bildung,
Forschung und Innovation, Bern
6
EnzOx2: Enzymatic oxidation/oxyfunctionalization
AVA‘s major tasks in the project:
• develop new bio-chemical technologies
• based on the use of oxidative enzymes
• to provide innovative solutions for the production of substitutes to
products with petro-chemical origin.
Cordinator: CIB, CSIC Madrid
Duration: 01.11.16 – 31.10.16
Budget: 5 Mio € / Funding 4.7 Mio €
Participants: 3 SMEs, 2 Large Enterprises, 6 research institutes / Universities
7
Joining European R&D?
What should you consider when making your decision
NO
- If you only look for the money
- If you want to start a defined project very soon
- If you do not want to share your knowledge and experiences
YES
- If European collaboration is part of your overall R&D strategy
- Working in an inspiring international framework is something you want for your company
A suggestion
If you can look at European projects in a way you look at your sales, than you should consider
participating. You should approach participation in proposals it like setting up a sales pipeline.
8The future belongs to sugar-based
chemistry
9CONTACT INFORMATION:
DR. GILBERT ANDERER
PHONE: +49 151 1577 3388
R&D
EMAIL: G.ANDERER@AVA-BIOCHEM.COM
AVABIOCHEM AG
WEBSITE: WWW.5-HMF.COM
BAARERSTRASSE 16
CH - 6302 ZUG
DISCLAIMER
These materials may not be used or relied upon for any purpose other than as specifically contemplated by a written agreement with AVALON Industries Ltd.
This information is only for qualified private investors, companies and institutional investors. All information in this document has been compiled with the greatest of care
and to the best of our current knowledge and belief. Its purpose is to describe the project as realistically as possible. At the present point in time we have to base our
calculations on (conservative) assumptions. Deviations during the realisation of the project can therefore not be ruled out. Even so, we would like to point out that AVALON
Industries AG can assume no warranty at the present point in time for the profitability of the overall project and hence the results expected in this project. Furthermore, we
would also like to point out that despite the 'De-risking' process of AVALON Industries AG, this investment has a risk capital character.
10You can also read
